MillerKnoll Inc
F:MHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MillerKnoll Inc
F:MHR
|
US |
|
S
|
Stockland Corporation Ltd
F:LN1
|
AU |
|
U
|
Unum Group
F:UUM
|
US |
|
P
|
Prudential PLC
F:PRU
|
UK |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
|
A
|
ACG Acquisition Company Ltd
OTC:ACGAF
|
VG |
|
I
|
Ingredion Inc
XMUN:CNP
|
US |
|
T
|
Thomson Reuters Corp
F:TOCB
|
CA |
|
T
|
Takeda Pharmaceutical Co Ltd
F:TKDA
|
JP |
|
U
|
United Therapeutics Corp
SWB:UTH
|
US |
Wall St Price Targets
MHR Price Targets Summary
MillerKnoll Inc
According to Wall Street analysts, the average 1-year price target for MHR is 31.17 EUR with a low forecast of 30.86 EUR and a high forecast of 32.08 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MHR's stock price target?
Price Target
31.17
EUR
According to Wall Street analysts, the average 1-year price target for MHR is 31.17 EUR with a low forecast of 30.86 EUR and a high forecast of 32.08 EUR.
What is the Revenue forecast for MillerKnoll Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for MillerKnoll Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 13%.
